Recent 8-K Filings

Material events and disclosures from public companies, summarized by AI.

XYZBlock, Inc.8-KJan 14, 2026High Impact

Block, Inc. Reports Amended Revolving Credit Agreement

On January 14, 2026, Block, Inc. entered into an Amended and Restated Revolving Credit Agreement with its lenders and Goldman Sachs Bank USA, as ad...

Item 1.01
Item 2.03
Item 9.01
WFCWELLS FARGO & COMPANY/MN8-KJan 14, 2026High Impact

Wells Fargo Reports Fourth Quarter 2025 Financial Results

On January 14, 2026, Wells Fargo & Company reported its results for the quarter ended December 31, 2025, via a news release (Ex. 99.1) and a 4Q25 Q...

Item 2.02
Item 7.01
Item 9.01
KOCOCA COLA CO8-KJan 14, 2026High Impact

The Coca-Cola Company Furnishes Leadership Changes and New Digital Role

The Coca-Cola Company announced leadership changes on January 14, 2026, effective March 31, 2026, including the creation of a new Chief Digital Off...

Item 5.02
Item 9.01
CCITIGROUP INC8-KJan 14, 2026High Impact

C Furnishes earnings results (Ex. 99.1)

On January 14, 2026, Citigroup Inc. announced its results for the quarter and year ended December 31, 2025, via an Exhibit 99.1 press release. The ...

Item 2.02
Item 9.01
BIIBBIOGEN INC.8-KJan 14, 2026High Impact

Biogen Inc. Reports Preliminary R&D Expense Estimate

Biogen Inc. anticipates a pre-tax charge of approximately $222 million for acquired in-process research and development, upfront and milestone expe...

Item 2.02
BACBANK OF AMERICA CORP /DE/8-KJan 14, 2026High Impact

BAC Furnishes earnings results (Ex. 99.1)

On January 14, 2026, Bank of America Corporation announced its financial results for the fourth quarter and year ended December 31, 2025, via Exhib...

Item 2.02
Item 7.01
Item 9.01
USBUS BANCORP \DE\8-KJan 13, 2026High Impact

U.S. Bancorp Furnishes Details on BTIG Acquisition

U.S. Bancorp announced on January 13, 2026, via Ex. 99.1 press release, its definitive agreement to acquire BTIG, LLC, a financial services firm. T...

Item 3.02
Item 7.01
Item 9.01
JPMJPMORGAN CHASE & CO8-KJan 13, 2026High Impact

JPMorgan Chase & Co. Furnishes 4Q25 Financial Results and Outlook Presentation

JPMorgan Chase & Co. held an investor presentation on January 13, 2026, to review its 2025 fourth quarter earnings, furnishing slides via Exhibit 9...

Item 7.01
Item 9.01
JPMJPMORGAN CHASE & CO8-KJan 13, 2026High Impact

JPMorgan Chase & Co. Reports Fourth-Quarter and Full-Year 2025 Financial Results

JPMorgan Chase & Co. reported net income of $13.0 billion ($4.63 per share), a decrease from $14.0 billion ($4.81 per share) in (via Ex. 99.1 and I...

Item 2.02
Item 9.01
DALDELTA AIR LINES, INC.8-KJan 13, 2026High Impact

Delta Air Lines Furnishes December Quarter and Full Year 2025 Financial Results and Aircraft Order

Delta Air Lines furnished its December quarter and full year 2025 financial results, reporting record revenue for both periods (via Ex. 99.1). The ...

Item 1.01
Item 2.02
Item 9.01
AVGOBroadcom Inc.8-KJan 13, 2026High Impact

Broadcom Inc. Reports $4.5 Billion Senior Notes Offering

Broadcom Inc. entered into an underwriting agreement on January 6, 2026, with BofA Securities, Inc. and J.P. Morgan Securities LLC to issue and sel...

Item 8.01
Item 9.01
UBERUber Technologies, Inc8-KJan 12, 2026High Impact

Uber Technologies, Inc. Reports Changes to Non-GAAP and Segment Reporting Measures

Uber Technologies, Inc. announced significant changes to its financial reporting, effective beginning in the first quarter of 2026. The Company wil...

Item 8.01
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD8-KJan 12, 2026Medium Impact

Teva Furnishes Update on J.P. Morgan Healthcare Conference Presentation

Teva Pharmaceutical Industries Ltd. issued a press release on January 11, 2026, in connection with its presentation at the 44th Annual J.P. Morgan ...

Item 2.02
Item 9.01
REGNREGENERON PHARMACEUTICALS, INC.8-KJan 12, 2026Medium Impact

Regeneron Furnishes Preliminary Q4 2025 Financial Update at J.P. Morgan Conference

Regeneron Pharmaceuticals, Inc. furnished a corporate update presentation (via Ex. 99.1) at the 44th Annual J.P. Morgan Healthcare Conference on Ja...

Item 2.02
Item 7.01
Item 9.01
MSTRStrategy Inc8-KJan 12, 2026High Impact

MSTR Furnishes Regulation FD disclosure

On January 12, 2026, Strategy announced updates regarding its at-the-market (ATM) offering program and bitcoin holdings. From January 5-11, 2026, t...

Item 7.01
Item 8.01
MRNAModerna, Inc.8-KJan 12, 2026High Impact

MRNA Reports earnings results (Ex. 99.1)

Moderna, Inc. furnished preliminary financial information for the fiscal year ended December 31, 2025, and provided business updates at the 44th An...

Item 2.02
Item 7.01
Item 9.01
LULUlululemon athletica inc.8-KJan 12, 2026High Impact

lululemon athletica inc. Furnishes Updated FY25 Revenue and Earnings Expectations

On January 12, 2026, lululemon athletica inc. issued a press release (via Ex. 99.1) updating its financial expectations for the fourth fiscal quart...

Item 7.01
Item 9.01
BYNDBEYOND MEAT, INC.8-KJan 12, 2026High Impact

Beyond Meat, Inc. Reports Supplemental Indenture for Notes Guarantee

Beyond Meat, Inc. and its wholly-owned subsidiary, Beyond Meat EU B.V. (the "New Guarantor"), entered into a First Supplemental Indenture on Januar...

Item 1.01
Item 2.03
Item 9.01
BMYBRISTOL MYERS SQUIBB CO8-KJan 12, 2026Medium Impact

Bristol-Myers Squibb Company Furnishes Investor Presentation

On January 12, 2026, Bristol-Myers Squibb Company posted an investor presentation to its website at www.bms.com/investors/events-and-presentations....

Item 7.01
Item 9.01
ARCCARES CAPITAL CORP8-KJan 12, 2026High Impact

Ares Capital Corporation Reports $750M Notes Issuance and Interest Rate Swap

Ares Capital Corporation entered into a Fifth Supplemental Indenture with U.S. Bank Trust Company, National Association, on January 12, 2026, for t...

Item 1.01
Item 2.03
Item 2.03
Item 8.01
Item 9.01
Load More Filings

Showing 20 so far